AI assistant
Sending…
RESMED INC — Director's Dealing 2014
Feb 13, 2014
30071_dirs_2014-02-13_6e2d90fc-462f-4644-b438-1ce0a72a547d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-11
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-11 | ResMed Common Stock | M | 5000 | $15.520 | Acquired | 73955.566 | Direct |
| 2014-02-11 | ResMed Common Stock | S | 5000 | $45.591 | Disposed | 68955.566 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-11 | ResMed Stock Options | $15.52 | M | 5000 | Disposed | 2015-11-20 | ResMed Common Stock (5000) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29